Author:
Zawinell Anette,Schwabe Ulrich
Publisher
Springer Berlin Heidelberg
Reference45 articles.
1. Abramson M, Puy R, Weiner J (2003) Allergen immunotherapy for asthma (Cochrane Review). Cochrane Libr. https://doi.org/10.1002/14651858.CD001186
2. Adkinson NF, Eggleston PA, Eney D, Goldstein EO, Schuberth KC et al (1997) A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 336:324–331
3. Arvidsson MB, Löwhagen O, Rak S (2002) Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J Allergy Clin Immunol 109:777–783
4. BKK Dachverband (2019) Stellungnahme des BKK Dachverbandes e.V. vom 04. April 2019 zum Entwurf eines Gesetzes für mehr Sicherheit in der Arzneimittelversorgung (GSAV) BT-Drs. 19/8753. https://www.bkk-dachverband.de/fileadmin/user_upload/20190404_BKK_DV_Stellungnahme_GE_GSAV.pdf
5. Bousquet J, Hejjaoui A, Clauzel AM, Guerin B, Dhivert H, Skassa-Brociek W, Wichel FB (1988) Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 82:971–977